- Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
-
Hirano T, Arai E, Fujimoto M, Nakayama Y, Tian Y, Ito N, Makabe T, Yamagami W, Susumu N, Aoki D, Kanai Y
- KMID: 2537965
- J Gynecol Oncol.
- 2022 Nov;33(6):e74.
- doi: 10.3802/jgo.2022.33.e74
Objective The aim of this study was to establish criteria that would indicate whether fertility preservation therapy would likely be safe for patients aged 40 years or less with endometrioid endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
-
Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D
- KMID: 2404016
- J Gynecol Oncol.
- 2018 Mar;29(2):e21.
- doi: 10.3802/jgo.2018.29.e21
OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking.... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
-
Saotome K, Yamagami W, Machida H, Ebina Y, Kobayashi Y, Tabata T, Kaneuchi M, Nagase S, Enomoto T, Aoki D, Mikami M
- KMID: 2511568
- Obstet Gynecol Sci.
- 2021 Jan;64(1):80-89.
- doi: 10.5468/ogs.20186
Objective Regional lymph node (LN) dissection is a standard surgical procedure for endometrial cancer, but there is currently no clear consensus on its therapeutic significance. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
-
Ikeda M, Shida M, Shigeta S, Nagase S, Takahashi F, Yamagami W, Katabuchi H, Yaegashi N, Aoki D, Mikami M
- KMID: 2526401
- J Gynecol Oncol.
- 2021 May;32(3):e44.
- doi: 10.3802/jgo.2021.32.e44
Objective: The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology
-
Mikami M, Nagase S, Yamagami W, Ushijma K, Tashiro H, Katabuchi , Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology (JSOG)
- KMID: 2413435
- J Gynecol Oncol.
- 2017 Jul;28(4):e52.
- doi: 10.3802/jgo.2017.28.e52
OBJECTIVE: Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with... -
- CITED
-
- Close
- SHARE
-
- Close
- TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
-
Akahane T, Masuda K, Hirasawa A, Kobayashi Y, Ueki A, Kawaida M, Misu K, Nakamura K, Nagai S, Chiyoda T, Yamagami W, Hayashi S, Kataoka F, Banno K, Sugano K, Okita H, Kosaki K, Nishihara H, Aoki D
- KMID: 2537895
- J Gynecol Oncol.
- 2022 Jul;33(4):e50.
- doi: 10.3802/jgo.2022.33.e50
Objective Precursor lesions may be identified in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in patients with pathogenic variants of BRCA1/2. Serous tubal intraepithelial carcinoma (STIC) is considered a precursor of... -
- CITED
-
- Close
- SHARE
-
- Close
- Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
-
Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H, Aoki D
- KMID: 2465192
- J Gynecol Oncol.
- 2020 Jan;31(1):e18.
- doi: 10.3802/jgo.2020.31.e18
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
-
Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D
- KMID: 2511956
- J Gynecol Oncol.
- 2020 Jul;31(4):e45.
- doi: 10.3802/jgo.2020.31.e45
Objective: International Federation of Gynecology and Obstetrics (FIGO) staging for ovarian, fallopian tube, and peritoneal cancers was revised in 2014. The aim of this study is to clarify whether the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical statistics of gynecologic cancers in Japan
-
Yamagami W, Nagase S, Takahashi , Ino K, Hachisuga , Aoki D, Katabuchi
- KMID: 2413460
- J Gynecol Oncol.
- 2017 Mar;28(2):e32.
- doi: 10.3802/jgo.2017.28.e32
Cervical, endometrial, and ovarian cancers, have both high morbidity and mortality among the gynecologic malignant tumors in Japan. The present study was conducted using both the population-based cancer registry and... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
-
Kondo E, Yoshida K, Tabata T, Kobayashi Y, Yamagami W, Ebina Y, Kaneuchi M, Nagase S, Machida H, Mikami M
- KMID: 2536837
- J Gynecol Oncol.
- 2022 Mar;33(2):e14.
- doi: 10.3802/jgo.2022.33.e14
Objective The study compared the treatment outcomes of surgery versus radiotherapy, including concurrent chemoradiotherapy, in stage Ib2–IIb cervical adenocarcinoma patients in Japan. Methods Of 57,470 patients diagnosed with stage I–IV cervical cancer from... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
-
Ikeda Y, Furusawa A, Kitagawa R, Tokinaga A, Ito F, Ukita M, Nomura H, Yamagami W, Tanabe H, Mikami M, Takeshima , Yaegashi N
- KMID: 2363323
- J Gynecol Oncol.
- 2016 May;27(3):e29.
- doi: 10.3802/jgo.2016.27.e29
OBJECTIVE: Although radiation therapy (RT) and concurrent chemoradiotherapy (CCRT) are the global standards for adjuvant therapy treatment in cervical cancer, many Japanese institutions choose chemotherapy (CT) because of the low... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
-
Machida H, Matsuo K, Kobayashi Y, Momomura M, Takahashi F, Tabata T, Kondo E, Yamagami W, Ebina Y, Kaneuchi M, Nagase S, Mikami M
- KMID: 2536989
- J Gynecol Oncol.
- 2022 May;33(3):e26.
- doi: 10.3802/jgo.2022.33.e26
Objective To assess the efficacy of the FIGO 2018 classification system for nodal-specific classifications for early-stage cervical cancer; specifically, to examine the impact of nodal metastasis on survival and the effect... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality indicators for cervical cancer care in Japan
-
Watanabe T, Mikami M, Katabuchi , Kato S, Kaneuchi M, Takahashi , Nakai H, Nagase S, Niikura H, Mandai M, Hirashima , Yanai H, Yamagami W, Kamitani S, Higashi T
- KMID: 2431230
- J Gynecol Oncol.
- 2018 Nov;29(6):e83.
- doi: 10.3802/jgo.2018.29.e83
OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
-
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M
- KMID: 2536009
- J Gynecol Oncol.
- 2022 Jan;33(1):e3.
- doi: 10.3802/jgo.2022.33.e3
Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
-
Shigeta S, Nagase S, Mikami M, Ikeda M, Shida M, Sakaguchi , Ushioda N, Takahashi , Yamagami W, Yaegashi N, Udagawa Y, Katabuchi
- KMID: 2413202
- J Gynecol Oncol.
- 2017 Nov;28(6):e76.
- doi: 10.3802/jgo.2017.28.e76
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) published the first practice guideline for endometrial cancer in 2006. The JSGO guideline evaluation committee assessed the effect of this guideline introduction... -
- CITED
-
- Close
- SHARE
-
- Close
